Gilead Sciences reports positive data in trial of remdesivir for COVID-19 treatment
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate […]